Daily FNArena News

Daily update on share prices and consensus price targets.

Qantas delivered improved traffic statistics for April and brokers expect the trend to continue.

This week’s Tweets on Twitter by your Editor.

Ahead of the Herd’s Rick Mills suggests infrastructure programs will support commodities, which should keep junior resource companies on the radar screens of investors.

June usually is a tough month for commodities and the US dollar, finds Barclays.

The recent Cooper Review noted a lack of Australian super products tailored to meet the needs of retirees. Smurfs can overcome these limitations with appropriate portfolios.

What impact will Germany’s announced nuclear energy phase-out have on the uranium market?

While brokers in the FNArena databse favour Sell ratings on Sigma Pharmaeceutical, Morgan Stanley has gone against the trend and upgraded to an Overweight rating.

While its share price has risen strongly over the past year Imdex continues to offer value and with earnings risk to the upside Moelis rates the stock a Buy.

A snapshot of economist responses to the weakest quarter since the 1991 recession and its implication for monetary policy.